ARCHIVES

The Cancer Letter Obtains “Confidential” Documents From Duke IRB Investigation

This article is from The Cancer Letter archive.

Vol. 36 No. 18 | May 14, 2010

Download PDF Visit The Full Archive

Related Articles

Phase III Kyprolis Trial Fails OS Primary Endpoint

August 29, 2014

Prevention Facility For Intramural Research Approved, Also Would Involve Academic Investigators

November 1, 1991

FCRC Contract Will Be Completed In Five Parts, Two of Them For Small Business; RFP Available July 24

July 3, 1981

Six Compounds Carcinogenic, Risk to Humans, CH Subgroup Finds

February 2, 1979

FDA, NCI Seek Compromise On Survival Endpoints

June 16, 1989

FDA Grants Accelerated Approval to Imbruvica

November 29, 2013